See past the headline price. Estimate your real 3-, 6- and 12-month cost — including dose-based increases and extras — and compare it against a flat-rate baseline.
Compounded tirzepatide is titrated upward, so the headline price often isn't your real cost. Enter a provider's terms to see your projected 3-, 6- and 12-month total, then compare it against a flat-rate baseline.
Use this for membership models (e.g., Mochi) where a program fee is charged on top of medication. Leave at 0 if it's already included in the price above.
Default $186 = NexLife's 12-month flat rate. Lowest flat baseline we found is ~$125 (Trimi annual).
Enter a provider's terms from its pricing page or your quote. For dose-tiered providers, set the starter and maintenance prices and how many months you expect to spend at the starter dose before reaching maintenance. Add any monthly shipping, visit or lab fees that aren't bundled. The baseline lets you compare against a flat-rate provider's all-inclusive price. This is an estimate for comparison only — verify current pricing directly, and see starter vs maintenance price and the Price Index.
Multiply the monthly all-in price (medication plus any shipping, visit and lab fees) across 12 months. For dose-tiered providers, account for the higher maintenance price after you titrate up. This calculator does that and compares the total against a flat-rate baseline.
Advertised prices are often a starter dose on a prepaid annual plan, and dose-tiered providers raise the price as your dose increases. Your real cost is the price at your maintenance dose across a year, plus any separately billed services.
No. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved. Compounded tirzepatide is prepared by licensed pharmacies and is not FDA-approved.